Nithya V, Rathinam S, Siva Ganesa Karthikeyan R, Lalitha P. A ten year study of prevalence, antimicrobial susceptibility pattern, and genotypic characterization of Methicillin resistant Staphylococcus aureus causing ocular infections in a tertiary eye care hospital in South India. Infect Genet Evol. 2019;69:203-210 pubmed publisher

Hu Y, Yang H, Wang J, Zhang Y, Yu J, Wei H. Comparison between a chimeric lysin ClyH and other enzymes for extracting DNA to detect methicillin resistant Staphylococcus aureus by quantitative PCR. World J Microbiol Biotechnol. 2016;32:1 pubmed publisher

Utter B, Deutsch D, Schuch R, Winer B, Verratti K, Bishop Lilly K, et al. Beyond the chromosome: the prevalence of unique extra-chromosomal bacteriophages with integrated virulence genes in pathogenic Staphylococcus aureus. PLoS ONE. 2014;9:e100502 pubmed publisher

Mohamed M, Hamed M, Panitch A, Seleem M. Targeting methicillin-resistant Staphylococcus aureus with short salt-resistant synthetic peptides. Antimicrob Agents Chemother. 2014;58:4113-22 pubmed publisher

Kumar A, Khan I, Sharma P, K S, Ella K. Evaluation of activity of recombinant lysostaphin against isolates of meticillin-resistant Staphylococcus aureus from Indian hospitals. J Med Microbiol. 2014;63:763-766 pubmed publisher

Desbois A, Sattar A, Graham S, Warn P, Coote P. MRSA decolonization of cotton rat nares by a combination treatment comprising lysostaphin and the antimicrobial peptide ranalexin. J Antimicrob Chemother. 2013;68:2569-75 pubmed publisher

Huang C, Hsu J, Chung P, Cheng W, Jiang Y, Ju Y. Site-specific N-glycosylation of caprine lysostaphin restricts its bacteriolytic activity toward Staphylococcus aureus. Anim Biotechnol. 2013;24:129-47 pubmed publisher

Lu H, Gu M, Huang Q, Huang J, Lu W, Lu H, et al. Hydrogen/deuterium exchange mass spectrometry and site-directed disulfide cross-linking suggest an important dynamic interface between the two lysostaphin domains. Antimicrob Agents Chemother. 2013;57:1872-81 pubmed publisher

Okumura A, Suzuki T, Miyatake H, Okabe T, Hashimoto Y, Miyakawa T, et al. Leukocyte cell-derived chemotaxin 2 is a zinc-binding protein. FEBS Lett. 2013;587:404-9 pubmed publisher

Chen Y, Simmonds R, Young J, Timkovich R. Solution structure of the recombinant target recognition domain of zoocin A. Proteins. 2013;81:722-7 pubmed publisher

Potapova I, Eglin D, Laschke M, Bischoff M, Richards R, Moriarty T. Two-step labeling of Staphylococcus aureus with Lysostaphin-Azide and DIBO-Alexa using click chemistry. J Microbiol Methods. 2013;92:90-8 pubmed publisher

Levinger O, Bikels Goshen T, Landau E, Fichman M, Shapira R. Epigallocatechin gallate induces upregulation of the two-component VraSR system by evoking a cell wall stress response in Staphylococcus aureus. Appl Environ Microbiol. 2012;78:7954-9 pubmed publisher

Houry A, Gohar M, Deschamps J, Tischenko E, Aymerich S, Gruss A, et al. Bacterial swimmers that infiltrate and take over the biofilm matrix. Proc Natl Acad Sci U S A. 2012;109:13088-93 pubmed publisher

Sabala I, Jonsson I, Tarkowski A, Bochtler M. Anti-staphylococcal activities of lysostaphin and LytM catalytic domain. BMC Microbiol. 2012;12:97 pubmed publisher

Vipra A, Desai S, Roy P, Patil R, Raj J, Narasimhaswamy N, et al. Antistaphylococcal activity of bacteriophage derived chimeric protein P128. BMC Microbiol. 2012;12:41 pubmed publisher

Wu H, Fang W, Yuan J, Peng H, Zhang X, Wang Y, et al. [Site-directed mutagenesis and sulfhydryl PEGylation of lysostaphin]. Sheng Wu Gong Cheng Xue Bao. 2011;27:1623-30 pubmed

Schmelcher M, Powell A, Becker S, Camp M, Donovan D. Chimeric phage lysins act synergistically with lysostaphin to kill mastitis-causing Staphylococcus aureus in murine mammary glands. Appl Environ Microbiol. 2012;78:2297-305 pubmed publisher

Satishkumar R, Vertegel A. Antibody-directed targeting of lysostaphin adsorbed onto polylactide nanoparticles increases its antimicrobial activity against S. aureus in vitro. Nanotechnology. 2011;22:505103 pubmed publisher

Liu H, Gao Y, Yu L, Jones R, Elkins C, Hart M. Inhibition of Staphylococcus aureus by lysostaphin-expressing Lactobacillus plantarum WCFS1 in a modified genital tract secretion medium. Appl Environ Microbiol. 2011;77:8500-8 pubmed publisher

Miao J, Pangule R, Paskaleva E, Hwang E, Kane R, Linhardt R, et al. Lysostaphin-functionalized cellulose fibers with antistaphylococcal activity for wound healing applications. Biomaterials. 2011;32:9557-67 pubmed publisher

Belyansky I, Tsirline V, Montero P, Satishkumar R, Martin T, Lincourt A, et al. Lysostaphin-coated mesh prevents staphylococcal infection and significantly improves survival in a contaminated surgical field. Am Surg. 2011;77:1025-31 pubmed

Lawson T, Connally R, Vemulpad S, Piper J. Optimization of a two-step permeabilization fluorescence in situ hybridization (FISH) assay for the detection of Staphylococcus aureus. J Clin Lab Anal. 2011;25:359-65 pubmed publisher

Patel D, Husain M, Vidaillac C, Steed M, Rybak M, Seo S, et al. Mechanisms of in-vitro-selected daptomycin-non-susceptibility in Staphylococcus aureus. Int J Antimicrob Agents. 2011;38:442-6 pubmed publisher

Fenton M, Ross R, McAuliffe O, O Mahony J, Coffey A. Characterization of the staphylococcal bacteriophage lysin CHAP(K). J Appl Microbiol. 2011;111:1025-35 pubmed publisher

Yurko Y, McDeavitt K, Kumar R, Martin T, Prabhu A, Lincourt A, et al. Antibacterial mesh: a novel technique involving naturally occurring cellular proteins. Surg Innov. 2012;19:20-6 pubmed publisher

Satishkumar R, Sankar S, Yurko Y, Lincourt A, Shipp J, Heniford B, et al. Evaluation of the antimicrobial activity of lysostaphin-coated hernia repair meshes. Antimicrob Agents Chemother. 2011;55:4379-85 pubmed publisher

Belyansky I, Tsirline V, Martin T, Klima D, Heath J, Lincourt A, et al. The addition of lysostaphin dramatically improves survival, protects porcine biomesh from infection, and improves graft tensile shear strength. J Surg Res. 2011;171:409-15 pubmed publisher

Aguinaga A, Francés M, del Pozo J, Alonso M, Serrera A, Lasa I, et al. Lysostaphin and clarithromycin: a promising combination for the eradication of Staphylococcus aureus biofilms. Int J Antimicrob Agents. 2011;37:585-7 pubmed publisher

Lawson T, Connally R, Iredell J, Vemulpad S, Piper J. Detection of Staphylococcus aureus with a fluorescence in situ hybridization that does not require lysostaphin. J Clin Lab Anal. 2011;25:142-7 pubmed publisher

Desbois A, Coote P. Bactericidal synergy of lysostaphin in combination with antimicrobial peptides. Eur J Clin Microbiol Infect Dis. 2011;30:1015-21 pubmed publisher

Jonsson I, Juuti J, Francois P, AlMajidi R, Pietiäinen M, Girard M, et al. Inactivation of the Ecs ABC transporter of Staphylococcus aureus attenuates virulence by altering composition and function of bacterial wall. PLoS ONE. 2010;5:e14209 pubmed publisher

Feizabadi M, Ghodousi A, Nomanpour B, Omrani M, Shahcheraghi F. Development of a modified DNA extraction method for pulsed-field gel electrophoresis analysis of Staphylococcus aureus and enterococci without using lysostaphin. J Microbiol Methods. 2011;84:144-6 pubmed publisher

Gargis S, Heath H, LeBlanc P, Dekker L, Simmonds R, Sloan G. Inhibition of the activity of both domains of lysostaphin through peptidoglycan modification by the lysostaphin immunity protein. Appl Environ Microbiol. 2010;76:6944-6 pubmed publisher

Cui F, Li G, Huang J, Zhang J, Lu M, Lu W, et al. Extension of nasal anti-Staphylococcus aureus efficacy of lysostaphin by its incorporation into a chitosan-o/w cream. Drug Deliv. 2010;17:617-23 pubmed publisher

Balibar C, Shen X, Tao J. The mevalonate pathway of Staphylococcus aureus. J Bacteriol. 2009;191:851-61 pubmed publisher

Francius G, Domenech O, Mingeot Leclercq M, Dufrêne Y. Direct observation of Staphylococcus aureus cell wall digestion by lysostaphin. J Bacteriol. 2008;190:7904-9 pubmed publisher

Nuryastuti T, van der Mei H, Busscher H, Kuijer R, Aman A, Krom B. recA mediated spontaneous deletions of the icaADBC operon of clinical Staphylococcus epidermidis isolates: a new mechanism of phenotypic variations. Antonie Van Leeuwenhoek. 2008;94:317-28 pubmed publisher

Zander J, Besier S, Saum S, Dehghani F, Loitsch S, Brade V, et al. Influence of dTMP on the phenotypic appearance and intracellular persistence of Staphylococcus aureus. Infect Immun. 2008;76:1333-9 pubmed

Ramadurai L, Jayaswal R. Molecular cloning, sequencing, and expression of lytM, a unique autolytic gene of Staphylococcus aureus. J Bacteriol. 1997;179:3625-31 pubmed

Thumm G, Gotz F. Studies on prolysostaphin processing and characterization of the lysostaphin immunity factor (Lif) of Staphylococcus simulans biovar staphylolyticus. Mol Microbiol. 1997;23:1251-65 pubmed

Baba T, Schneewind O. Target cell specificity of a bacteriocin molecule: a C-terminal signal directs lysostaphin to the cell wall of Staphylococcus aureus. EMBO J. 1996;15:4789-97 pubmed

Dehart H, Heath H, Heath L, Leblanc P, Sloan G. The lysostaphin endopeptidase resistance gene (epr) specifies modification of peptidoglycan cross bridges in Staphylococcus simulans and Staphylococcus aureus. Appl Environ Microbiol. 1995;61:1475-9 pubmed

Recsei P, Gruss A, Novick R. Cloning, sequence, and expression of the lysostaphin gene from Staphylococcus simulans. Proc Natl Acad Sci U S A. 1987;84:1127-31 pubmed

Wang X, Wilkinson B, Jayaswal R. Sequence analysis of a Staphylococcus aureus gene encoding a peptidoglycan hydrolase activity. Gene. 1991;102:105-9 pubmed